BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Indications
/
Insomnia
Insomnia
11 competing products in clinical development for Insomnia.
Pipeline by Phase
Pre-clinical
2
Phase 1
3
Phase 3
3
Approved
3
All Products (11)
Product
Company
Stage
Status
Hype
Zolpidem (Myslee®) + placebo
Astellas Pharma
Approved
Completed
43
zolpidem
Astellas Pharma
Approved
Completed
43
Lemborexant (LEM) 5 mg (Z-Drug-mono cohort) + Lemborexant (LEM) 5 mg (SUV-mono cohort) + Lemborexant (LEM) 5 mg (SUV-combination cohort) + Lemborexant (LEM) 5 mg (RMT-combination cohort)
Eisai
Approved
Completed
43
Lemborexant + Lemborexant + Lemborexant-matched placebo + Zolpidem tartrate + Zolpidem-matched placebo
Eisai
Phase 3
Completed
40
LEM 5 mg + LEM 10 mg
Eisai
Phase 3
Completed
40
Eszopiclone 1 mg- Elderly + Eszopiclone 2 mg- Elderly + Eszopiclone 3 mg- Non-elderly + Eszopiclone 2 mg- Non-elderly
Eisai
Phase 3
Completed
40
E2006 1.0 mg + E2006 2.5 mg + E2006 5.0 mg + E2006 10.0 mg + E2006 25.0 mg + E2006 50.0 mg + E2006 100 mg + E2006 200 mg + Zolpidem 10 mg + E2006 Matched Placebo or Zolpidem Matched Placebo + E2006 Matched Placebo
Eisai
Phase 1
Completed
29
E2006
Eisai
Phase 1
Completed
29
Eszopiclone 3 mg + Eszopiclone 1 mg
Eisai
Phase 1
Completed
29
Eszopiclone
Eisai
Pre-clinical
Completed
26
Eszopiclone
Eisai
Pre-clinical
Completed
26